|Bid||2.530 x 69100|
|Ask||2.540 x 62800|
|Day's Range||2.480 - 2.620|
|52 Week Range||2.210 - 8.770|
|PE Ratio (TTM)||-39.61|
|Earnings Date||Sep 20, 2017 - Sep 25, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||2.88|
Rite Aid announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 360 pharmacies in Michigan and South Carolina without a prescription, subject to state regulations.
Fred’s Inc. — the pharmacy and general merchandise retailer that recently saw its plans of becoming the third-largest drugstore chain in the U.S. shattered — announced July 19 that Jason Jenne was appointed executive vice president and CFO of Fred’s, effective immediately. Jenne replaces Rick Hans in the position. Hans joined Fred’s in April 2016 under then-Fred’s CEO Jerry A. Shore.
The Rite Aid that will emerge from the WBA deal will be much different than the company that existed before the deal. Walgreens was going to buy RAD for $9.4 billion, or about $9 per share. The Federal Trade Commission (FTC) didn’t like that idea, so it told Walgreens and Rite Aid to go back to the drawing board.